SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-24-005049
Filing Date
2024-08-09
Accepted
2024-08-09 17:11:34
Documents
1
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4244
  Complete submission text file 0000902664-24-005049.txt   6395
Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200, PMB 1237 SAN JUAN PR 00901-1607
Business Address
Nichols Weston (Reporting) CIK: 0001746376 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39231 | Film No.: 241193958

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Reporting) CIK: 0001910456 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39231 | Film No.: 241193957